Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study [Yahoo! Finance]
Pulse Biosciences, Inc (PLSE)
Last pulse biosciences, inc earnings: 11/7 03:42 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.pulsebiosciences.com
Company Research
Source: Yahoo! Finance
study, marking a significant milestone in the company's clinical development pipeline. The study is designed to evaluate the safety and effectiveness of the company's proprietary Nano-Pulse Stimulation (“NPS”) technology for the treatment of atrial fibrillation (AF), a common cardiac arrhythmia. The initiation of patient enrollment underscores Pulse Biosciences' continued progress in advancing its cardiac ablation platform. Management highlighted that the NANOPULSE-AF study is a critical step toward potential regulatory approval and commercialization of its NPS-based therapy in the large and growing AF treatment market. The trial is expected to generate pivotal data supporting the clinical utility of this novel, non-thermal energy modality. Price Performance PLSE's shares have plunged 6.5% since the announcement of the study initiation on April 7. The company's shares have gained 36% in the year-to-date period against the industry's 13.7% decline. The S&P 500 has decreased 0.7%
Show less
Read more
Impact Snapshot
Event Time:
PLSE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PLSE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PLSE alerts
High impacting Pulse Biosciences, Inc news events
Weekly update
A roundup of the hottest topics
PLSE
News
- Pulse Biosciences to Host Analyst Event on April 25, 2026 [Yahoo! Finance]Yahoo! Finance
- Pulse Biosciences to Host Analyst Event on April 25, 2026Business Wire
- Pulse Biosciences Strengthens Executive Leadership TeamBusiness Wire
- Pulse Biosciences: Promising Catheter Technology, Weak Risk-Reward For Now [Seeking Alpha]Seeking Alpha
- Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial FibrillationBusiness Wire
PLSE
Earnings
- 2/19/26 - Beat
PLSE
Sec Filings
- 4/16/26 - Form 8-K
- 4/9/26 - Form 8-K
- 4/7/26 - Form 8-K
- PLSE's page on the SEC website